Suppliers and packagers for OSMITROL 20% IN WATER IN PLASTIC CONTAINER

OSMITROL 20% IN WATER IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Baxter Hlthcare	OSMITROL 20% IN WATER IN PLASTIC CONTAINER	mannitol	INJECTABLE;INJECTION	013684	NDA	Baxter Healthcare Company	0338-0353-03	500 mL in 1 BAG (0338-0353-03)	1964-06-08
Baxter Hlthcare	OSMITROL 20% IN WATER IN PLASTIC CONTAINER	mannitol	INJECTABLE;INJECTION	013684	NDA	Baxter Healthcare Company	0338-0357-02	250 mL in 1 BAG (0338-0357-02)	1964-06-08
Baxter Hlthcare	OSMITROL 20% IN WATER IN PLASTIC CONTAINER	mannitol	INJECTABLE;INJECTION	013684	NDA	Baxter Healthcare Company	0338-0357-03	500 mL in 1 BAG (0338-0357-03)	1964-06-08

OSMITROL 20% IN WATER IN PLASTIC CONTAINER Suppliers: Who Manufactures and Supplies the 20% Osmolality OSMITROL Solution?

Last updated: May 25, 2026

OSMITROL 20% in water in plastic container is a marketed radiographic contrast-like solution used as an imaging agent in clinical settings. Supplier and manufacturing visibility for this specific trade presentation is driven by the product’s NDC-to-manufacturer mapping, distribution agreements, and whether the product is sold as brand-only or through authorized distributors.

This page lists the supplier pathways that determine who can supply OSMITROL 20% in water in plastic container, and the practical procurement routes used by hospitals, GPOs, and distributors.

What companies supply OSMITROL 20% in water in plastic container?

Fast answer: The only companies that can be treated as “suppliers” for this exact presentation are the labeler/manufacturer shown in the NDC record and the authorized distributors that carry the NDC in the US supply chain.

Procurement reality: For this trade unit (“in plastic container”), the supplier list typically breaks into three tiers:

1. NDC labeler/manufacturer (primary manufacturing site and legal marketer)
2. Authorized distributors / wholesale distributors (who can legally ship the NDC to customer accounts)
3. GPO supply chain and hospital procurement resellers (who sell through contracting channels)

Supplier evidence you would use in sourcing:

• NDC labeler/manufacturer for the exact dosage form and container (plastic)
• Wholesale distribution listing tied to that NDC
• Any direct-from-manufacturer ship programs for institutional accounts

How do you identify the NDC manufacturer for OSMITROL 20% in water in plastic container?

Best practice: Use the product’s exact NDC for the “20% in water” and the plastic container configuration. Then map:

• NDC labeler to the company listed as applicant/manufacturer in the FDA drug product listing
• Cross-check with wholesaler catalogs using the same NDC
• Confirm container type in the product listing and packaging insert/labeling

Why container type matters: Many radiology contrast and oral solution SKUs have multiple container configurations (glass vs plastic, unit sizes). Supplier availability can change by SKU even when strength is identical.

Which distributors carry OSMITROL 20% in water in plastic container through wholesale channels?

Fast answer: Distributors vary by NDC, contract status, and regional inventory, so the supplier list is best expressed as authorized wholesalers that can source the exact NDC rather than a static universal roster.

Typical wholesale distribution channels used for sterile and specialty injectables/oral imaging solutions:

• National wholesalers: inventory replenishment from manufacturer allocations
• Specialty distribution: cold-chain/specialty packaging capability when required
• GPO distribution: contract-driven resupply to hospitals

Procurement method that avoids stockouts: negotiate allocation terms for the exact NDC and plastic-container SKU, not only “OSMITROL 20%.”

Do generics or private-label versions of OSMITROL 20% in water in plastic container affect supplier options?

Fast answer: They do if an alternate labeler sells the same drug substance and strength under a different NDC or private label arrangement.

What to check:

• Whether the product is a brand-only listing versus multiple NDA/ANDA or ANDA labelers
• Whether there is an interchangeable generic that uses a different container specification
• Whether contract supply is split across multiple labelers

Commercial impact: Even when the active ingredient is the same, the plastic container presentation can keep the buying organization locked to a specific labeler/distributor unless interchangeability is explicitly accepted by the hospital pharmacy and procurement policy.

What manufacturing sites are behind OSMITROL 20% in water in plastic container?

Fast answer: Manufacturing sites are not determined by the trade name alone. They are determined by:

• the FDA listing for that NDC
• the labeler’s manufacturing network for that specific dosage form and container

How sites typically map to suppliers:

• One labeler can run multiple manufacturing sites for the same strength depending on lots
• A distributor usually does not change the manufacturing site; it changes the allocation and shipping relationship

How strong is the supplier concentration risk for OSMITROL 20% in water in plastic container?

Fast answer: Concentration risk is usually high for niche radiology solutions where:

• only a small number of NDC labelers exist for the exact container/strength SKU
• demand is stable while manufacturing is limited to a few compliant sites

What drives concentration:

• regulatory quality control for sterile/contrast-like products (if applicable)
• limited packaging-line capacity for “plastic container”
• contract allocations during supply tightness

What do hospitals and distributors do when OSMITROL 20% in water in plastic container supply is constrained?

Common mitigation actions used in US procurement:

• switch to an alternative NDC only if pharmacy policy permits (strength/container may be clinically equivalent)
• use an alternate distributor with verified inventory for the same NDC
• adjust reorder points based on lead time from labeler/distributor

Key operational point: supply substitution is constrained by the need for the same container and labeling used in protocols and pharmacy dispensing workflows.

Which documents confirm the supplier for OSMITROL 20% in water in plastic container?

Most authoritative evidence for supplier confirmation:

• FDA drug product listing tied to the exact NDC
• Wholesale distributor listing using the exact NDC
• Packaging label (outer carton and unit label) showing manufacturer/distributor
• Material purchase order terms specifying NDC and container type

How does supplier availability vary by geography for OSMITROL 20% in water in plastic container?

Fast answer: Availability tracks distribution footprints of wholesalers and allocations from the labeler. Geographic variance typically shows up as:

• different distributor options by region
• lead time changes based on regional allocations and safety stock

Procurement implication: When sourcing the plastic-container SKU, select distributors that can consistently source that exact NDC in your region.

Key Takeaways

• “Suppliers” for OSMITROL 20% in water in plastic container are determined by the exact NDC and the labeler/manufacturer shown in FDA listing, plus authorized wholesalers carrying that NDC.
• The plastic container presentation can change the supplier roster even when the strength stays at 20%.
• Supplier concentration risk rises when the exact SKU exists under a limited number of labelers/manufacturing sites.
• Confirm supplier identity using NDC-to-labeler mapping, distributor listings for the same NDC, and package label manufacturer/distributor markings.

FAQs

1. How do I confirm the manufacturer for OSMITROL 20% in water in plastic container on a purchase order?
   Use the exact NDC in the PO line item and require matching manufacturer/distributor labeling for that NDC.

2. Can the same OSMITROL 20% strength be supplied by multiple companies?
   Yes, if different labelers market the same strength under different NDCs or packaging configurations, including plastic-container variants.

3. What changes supplier options the most: strength or container type?
   Container type can matter because it can map to a different NDC and packaging label, changing which labeler/distributor can supply the SKU.

4. Do authorized distributors have different lead times for the same OSMITROL NDC?
   Yes. Allocation rules and regional inventory levels drive lead time variation across wholesalers.

5. What is the most reliable way to prevent receiving the wrong formulation presentation?
   Require NDC-level specificity and verify the received unit label/carton matches the intended container type.

References (APA)

1. FDA. (n.d.). Drug product database (Drugs@FDA and NDC/structured product labeling resources). U.S. Food and Drug Administration. https://www.accessdata.fda.gov